Mayo Clinic President’s Discovery Translation Program 2019 award winners
The Mayo Clinic President’s Discovery Translation Program announced 2019 award winners. This enterprisewide initiative provides targeted resources at critical stages of product or service development and supports projects that hold greatest promise for transformative advancement in safety, quality and efficacy of clinical care.
The translation of discovery to clinical and commercial applications fosters the premier position of Mayo Clinic as a center of excellence in medicine and biomedical innovation.
“PIKfyve Inhibitor Drug Development for Treatment of Malignant Peripheral Nerve Sheath Tumors”
Richard Bram, M.D. (PD '98), chair, Department of Pediatric and Adolescent Medicine, Mayo Clinic in Rochester
“Validation of a Humanized Bispecific Antibody for Rescuing PD-(L)1 Immune Checkpoint Inhibitor Resistance”
Haidong Dong, M.D., Ph.D. (IMM '01), Department of Urology, Mayo Clinic in Rochester
Jacob Orme, M.D., Ph.D. (I '19, HEMO '22), Department of Hematology/Oncology, Mayo Clinic in Rochester
“Pharmacological Mimics of Dopamine as Therapy for Pulmonary Fibrosis”
Daniel Tschumperlin, Ph.D. (I '18), Department of Physiology and Biomedical Engineering, Mayo Clinic in Rochester
"Synthetic Flavonol Lead Development for the Treatment of IPF"
Andrew Haak, Ph.D. (PHYS ’16), Department of Physiology and Biomedical Engineering, Mayo Clinic in Rochester